Genomic alterations, origin and evolution of B-cell non-Hodgkin's lymphoma

[Thoracic insufficiency syndrome].

Acta ortopedica mexicana·2021

Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trial.

European journal of neurology·2020

Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Journal of endocrinological investigation·2017

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Leukemia & lymphoma·2016

[Treatment of coronary three-vessel disease in patients above 75 years].

Deutsche medizinische Wochenschrift (1946)·2016

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Haematologica·2026

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Haematologica·2026

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Haematologica·2026

Normal platelet function in a patient with ARHGEF1 deficiency.

Haematologica·2026

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Haematologica·2026

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Haematologica·2026

Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan.

Cureus·2026

From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Behçet's Disease.

Frontiers in immunology·2026

TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.

Frontiers in immunology·2026

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Frontiers in immunology·2026

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities.

MedComm·2026

Molecular basis of post-translational neoantigen generation in rheumatoid arthritis: breaking immunological tolerance and implications for targeted therapy.

Frontiers in immunology·2026

Related Experiment Videos

Genomic alterations, origin and evolution of B-cell non-Hodgkin's lymphoma

Related Concept Videos

[Thoracic insufficiency syndrome].

Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trial.

Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.

NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

[Treatment of coronary three-vessel disease in patients above 75 years].

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Normal platelet function in a patient with ARHGEF1 deficiency.

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan.

From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Behçet's Disease.

TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities.

Molecular basis of post-translational neoantigen generation in rheumatoid arthritis: breaking immunological tolerance and implications for targeted therapy.

Related Experiment Videos

Genomic alterations, origin and evolution of B-cell non-Hodgkin's lymphoma

Related Concept Videos

Related Articles